Clinical trial
Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in…
NCT00021333 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00021333 |
|---|---|
| Title | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer |
| Official title | Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated Radiation Therapy And Granulocyte-Colony Stimulating Factor In Previously Irradiated Patients With Locally Recurrent Carcinoma Of The Head And Neck, And Lung |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Lung Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cisplatin, paclitaxel, radiation therapy |
| Enrollment | 29 |
| Start date | Sep 1, 1999 |
| Primary completion | Apr 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Jan 14, 2004 |
| Last update posted | Apr 17, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: